Back to Search
MOHAMMAD OWAIS, MD
MD
Neurology Physician
NPI: 1528347614IndividualAccepts Medicare
Specialties, Licenses & Credentials
Neurology PhysicianPrimary
Psychiatry & Neurology — Neurology
Code: 2084N0400X
S4363(TX)
CMS Specialties
PrimaryNEUROLOGY
Education
OTHER
Class of 2008
Research & Publications (20)
Potential use of liposomal diallyl sulfide in the treatment of experimental murine candidiasis.
PMID 19642969·Biosci Rep·2010
7-preclinical
Protective effect of liposomal formulation of tuftsin (a naturally occurring tetrapeptide) against cyclophosphamide-induced genotoxicity and oxidative stress in mice.
PMID 19374253·Indian J Biochem Biophys·2009
7-preclinical
Adjuvanticity and protective immunity of Plasmodium yoelii nigeriensis blood-stage soluble antigens encapsulated in fusogenic liposome.
PMID 18996429·Vaccine·2009
7-preclinical
Systemic absorption of triamcinolone acetonide after posterior sub-Tenon injection.
PMID 19464668·Am J Ophthalmol·2009
8-other
Immunomodulator effect of picroliv and its potential in treatment against resistant Plasmodium yoelii (MDR) infection in mice.
PMID 18551251·Pharm Res·2008
7-preclinical
Sperm membrane lipid liposomes can evoke an effective immune response against encapsulated antigen in BALB/c mice.
PMID 18789993·Vaccine·2008
7-preclinical
Dyspnea, pulmonary function and exercise capacity in adult Saudi patients with sickle cell disease.
PMID 18454219·Saudi Med J·2008
8-other
Escheriosome-mediated delivery of recombinant ribosomal L7/L12 protein confers protection against murine brucellosis.
PMID 17931756·Vaccine·2007
7-preclinical
Echocardiographic abnormalities in adolescent and adult Saudi patients with sickle cell disease.
PMID 17603714·Saudi Med J·2007
8-other
Liposomised recombinant ribosomal L7/L12 protein protects BALB/c mice against Brucella abortus 544 infection.
PMID 17296251·Vaccine·2007
7-preclinical
PLGA-microsphere mediated clearance of bilirubin in temporarily hyperbilirubinemic rats: an alternate strategy for the treatment of experimental jaundice.
PMID 16388906·Biochim Biophys Acta·2006
7-preclinical
Evaluation of anti-methicillin-resistant Staphylococcus aureus (MRSA) activity and synergy of some bioactive plant extracts.
PMID 17004300·Biotechnol J·2006
8-other
Role of fusogenic non-PC liposomes in elicitation of protective immune response against experimental murine salmonellosis.
PMID 16765503·Biochimie·2006
7-preclinical
Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model.
PMID 16709592·J Antimicrob Chemother·2006
7-preclinical
Fusogenic potential of sperm membrane lipids: nature's wisdom to accomplish targeted gene delivery.
PMID 16580670·FEBS Lett·2006
7-preclinical
Prophylactic use of liposomized tuftsin enhances the susceptibility of Candida albicans to fluconazole in leukopenic mice.
PMID 16420598·FEMS Immunol Med Microbiol·2006
7-preclinical
Enhanced efficacy of pH-sensitive nystatin liposomes against Cryptococcus neoformans in murine model.
PMID 16368700·J Antimicrob Chemother·2006
7-preclinical
Immunomodulator tuftsin increases the susceptibility of Cryptococcus neoformans to liposomal amphotericin B in immunocompetent BALB/c mice.
PMID 16308211·J Drug Target·2005
7-preclinical
Antimicrobial activity of clove oil and its potential in the treatment of vaginal candidiasis.
PMID 16390816·J Drug Target·2005
7-preclinical
Targeted drug delivery to macrophages in parasitic infections.
PMID 16305434·Curr Drug Deliv·2005
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 800 PEAKWOOD DR STE 5D
HOUSTON, TX 77090 - Phone
- (832) 353-2498
Quick Facts
- NPI
- 1528347614
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 18
- Publications
- 20
Are you this provider?
Claim Your Profile